Résultats de recherche pour ''
2018 BIO International Convention
4-7 June, 2018
Boston, USA
“The BIO International Convention is hosted by the Biotechnology Innovation Organization, which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products”.
GHP – Most Innovative Drug Discovery Company – West Europe & Award for Excellence in Mitochondrial Disease Drug Development
https://www.ghp-news.com/issues/biotechnology-awards-2018/20/
Approbation aux Etats-Unis du brevet d’utilisation des agonistes FXR contre la réplication de HBV
ENYO Pharma a obtenu l’approbation aux Etats-Unis du brevet d’utilisation des agonistes de FXR contre le virus de l’Hépatite B (HBV). Ce brevet a fait l’objet d’un accord de licence exclusive avec l’Inserm. Les agonistes FXR modifient la composition du complexe transcriptionnel du cccDNA de HBV provoquant une répression de l’expression du cccDNA.